Novel Perbutyrylated Glucose Derivatives of (–)-Epigallocatechin-3-Gallate Inhibit Cancer Cells Proliferation by Decreasing Phosphorylation of the EGFR: Synthesis, Cytotoxicity, and Molecular Docking
Ya Wang(Nanjing Medical University), Jun Sheng(Shanghai University of Traditional Chinese Medicine), Xiaojing Shen(Yunnan Agricultural University), Yun Niu(Yunnan Agricultural University), Cheng‐Ting Zi(Yunnan Agricultural University), Fawu Su(Yunnan University), Ning Zhang(Tianjin Children's Hospital), Lixia Wang(Second Affiliated Hospital of Nanjing Medical University), Dongying Zhang(Huaian First People’s Hospital), Yin-Rong Xie(Yunnan Agricultural University), Yi-Long Wu, Xuanjun Wang(Chuxiong Normal University)
Cited by 13
Related Papers
Gemcitabine and Cisplatin Induction Chemotherapy in Nasopharyngeal Carcinoma
|New England Journal of Medicine|2019|934
circRNA_0025202 Regulates Tamoxifen Sensitivity and Tumor Progression via Regulating the miR-182-5p/FOXO3a Axis in Breast Cancer
|Molecular Therapy|2019|513
Comprehensive review of emerging contaminants: Detection technologies, environmental impact, and management strategies
|Ecotoxicology and Environmental Safety|2024|438
RETRACTED ARTICLE: LncRNA BCRT1 promotes breast cancer progression by targeting miR-1303/PTBP3 axis
|Molecular Cancer|2020|396